The global vaccine market is growing significantly due increasing
initiatives by non-government organizations to provide immunization and improvement
in production technique of vaccine in the industry. Various
programs and campaigns are organized, such as Immunization Week by World Health Organization, to create awareness among
the population all over the world. Massive unexplored market in vaccine industry of developing economies are creating ample opportunities for
the vaccine market
to grow at a considerable rate in the coming years.
Explore Report at: https://www.psmarketresearch.com/market-analysis/vaccine-market
Moreover, the advanced research and development facilities, and new
and innovative product developments by the companies are propelling the growth of
the vaccine industry. Increasing prevalence of cancer and infectious diseases
is fuelling the growth of the vaccine market. Infectious diseases are the major
contributor to the human mortality and morbidity. According to World Health
Organization, approximately 129,064 cases were reported in 2013. Vaccination
has rescued millions of lives to provide secure and better life.
The vaccine market is categorized on the basis of type, technology, disease
indication and end users. On the basis of type of vaccine, the vaccine market can
be categorized as preventive vaccine and therapeutic vaccine. Preventive vaccine
leads the vaccine market due to increasing prevalence
of infectious disease and increasing investment by government and
non-government organizations.
Some of the companies operating in the global vaccine market are GlaxoSmithKline, Plc., CSL Limited, Sanofi, Medimmune, LLC., Emetgent Biosolutions, Inc., Novartis, AG, Pfizer, Inc., Merck & Co., Inc., Bavarian Nordic, and Johnson & Johnson.
No comments:
Post a Comment